Wellgistics Health, Inc.WGRXEarnings & Financial Report
Wellgistics Health, Inc. is a U.S.-headquartered healthcare services firm focused on the distribution of prescription pharmaceuticals, over-the-counter medications, and medical supplies. Its key customer segments include retail pharmacies, long-term care facilities, and independent healthcare providers across the domestic market.
WGRX Q4 FY2025 Key Financial Metrics
Revenue
$1.7M
Gross Profit
$-7.9M
Operating Profit
$-25.4M
Net Profit
$-27.9M
Gross Margin
-470.2%
Operating Margin
-1517.5%
Net Margin
-1667.2%
YoY Growth
N/A
EPS
$-0.24
Wellgistics Health, Inc. Q4 FY2025 Financial Summary
Wellgistics Health, Inc. reported revenue of $1.7M for Q4 FY2025, with a net profit of $-27.9M (-1667.2% margin). Cost of goods sold was $9.5M, operating expenses totaled $17.5M.
Key Financial Metrics
| Total Revenue | $1.7M |
|---|---|
| Net Profit | $-27.9M |
| Gross Margin | -470.2% |
| Operating Margin | -1517.5% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Wellgistics Health, Inc. Q4 FY2025 revenue of $1.7M breaks down across 2 segments, led by Products at $1.0M (60.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $1.0M | 60.7% |
| Other | $656.6K | 39.3% |
Wellgistics Health, Inc. Revenue by Segment — Quarterly Trend
Wellgistics Health, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | $1.0M | $2.6M | $7.5M | $10.7M |
| Other | $656.6K | $375.1K | $242.3K | — |
Wellgistics Health, Inc. Annual Revenue by Year
Wellgistics Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $23.3M).
Wellgistics Health, Inc. Quarterly Revenue & Net Profit History
Wellgistics Health, Inc. results over the last 4 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $1.7M | — | $-27.9M | -1667.2% |
| Q3 FY2025 | $3.0M | — | $-34.3M | -1139.0% |
| Q2 FY2025 | $7.8M | — | $-6.7M | -85.6% |
| Q1 FY2025 | $10.9M | — | $-32.4M | -298.5% |
Income Statement
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Revenue | $10.9M | $7.8M | $3.0M | $1.7M |
| YoY Growth | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Assets | $58.1M | $54.2M | $52.8M | $30.5M |
| Liabilities | $53.6M | $53.3M | $46.0M | $42.9M |
| Equity | $4.5M | $905255 | $6.8M | $-12.4M |
Cash Flow
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Operating CF | $-1.3M | $-2.1M | $-1.1M | $-6.3M |